HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,861-1,872 of 4,505
Drug study icon
TerminatedEUCTR 2010-018911-13

A Long-term, Multicenter, Open-Label Study to Evaluate the Safety and Tolerability of Flexible-Dose Oral Aripiprazole (OPC-14597) as Maintenance Treatment in Adolescent Patients with Schizophrenia...

This study ended early.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
Schizophrenia, BipolarityHistorical research record
Countries
Bulgaria, Hungary, Poland
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedEUCTR 2011-002514-37

A Long-term, Phase 3, Multicenter, Open-label Trial to Evaluate the Safety and Tolerability of Oral OPC-34712 as Maintenance Treatment in Adults with Schizophrenia

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Latvia
SchizophreniaHistorical research record
Countries
Latvia, Poland, Slovakia
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedEUCTR 2010-018408-96

A Multicenter, Double-Blind, Fixed-Dose, Long-Term Extension Trial of the Safety of Asenapine using Olanzapine as an Active Control in Subjects Diagnosed with Schizophrenia who Completed Protocol...

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
SchizophreniaHistorical research record
Countries
Bulgaria
Sponsor
Schering-Plough Research Institute, a Division of Schering
Drug study icon
CompletedEUCTR 2009-012568-14

A Phase 2, Multicenter, Open-label Study to Assess the Safety and Tolerability of Oral OPC-34712 as Monotherapy in Adult Patients with Schizophrenia

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
SchizophreniaHistorical research record
Countries
Bulgaria, Slovakia
Sponsor
Otsuka Pharmaceutical Development & Commercialization
Drug study icon
CompletedEUCTR 2016-003436-20

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Bulgaria
SchizophreniaHistorical research record
Countries
Bulgaria, Czechia, Hungary, + 2 others
Sponsor
ACADIA Pharmaceuticals Inc.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.